Mettler-Toledo International (NYSE:MTD – Get Free Report) had its price objective hoisted by equities research analysts at Robert W. Baird from $1,608.00 to $1,815.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird‘s target price points to a potential upside of 5.32% from the stock’s current price.
Other equities research analysts have also recently issued research reports about the company. Morgan Stanley increased their price target on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a report on Tuesday, October 13th. Rothschild & Co Redburn assumed coverage on Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective on the stock. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Weiss Ratings raised Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. Finally, UBS Group initiated coverage on Mettler-Toledo International in a report on Wednesday, September 9th. They set a “neutral” rating and a $1,460.00 price target on the stock. Six investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,516.92.
Check Out Our Latest Stock Analysis on Mettler-Toledo International
Mettler-Toledo International Stock Performance
NYSE MTD opened at $1,723.32 on Monday. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75. The stock’s 50 day simple moving average is $1,524.65 and its 200-day simple moving average is $1,345.95. The company has a market cap of $34.53 billion, a PE ratio of 37.34, a price-to-earnings-growth ratio of 3.46 and a beta of 1.16. Mettler-Toledo International has a 1-year low of $1,023.05 and a 1-year high of $1,806.58.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 EPS for the quarter, beating analysts’ consensus estimates of $12.13 by $0.44. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the prior year, the firm earned $11.15 EPS. Mettler-Toledo International’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that Mettler-Toledo International will post 47.49 EPS for the current fiscal year.
Insider Activity
In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 942 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the transaction, the chief executive officer owned 4,480 shares of the company’s stock, valued at $6,384,000. The trade was a 17.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.71% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter worth $26,000. Transamerica Financial Advisors LLC purchased a new stake in shares of Mettler-Toledo International in the second quarter valued at about $32,000. Provenance Wealth Advisors LLC acquired a new position in shares of Mettler-Toledo International during the third quarter worth about $54,000. Principia Wealth Advisory LLC increased its stake in shares of Mettler-Toledo International by 2,050.0% during the second quarter. Principia Wealth Advisory LLC now owns 43 shares of the medical instruments supplier’s stock worth $55,000 after acquiring an additional 41 shares during the period. Finally, Root Financial Partners LLC acquired a new position in shares of Mettler-Toledo International during the third quarter worth about $56,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.
Mettler-Toledo International Company Profile
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.
The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
Featured Articles
- Five stocks we like better than Mettler-Toledo International
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
